Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hepanova Inc. has 1 pending office action currently active in its prosecution pipeline. The portfolio involves 1 distinct examiner, which simplifies the coordination required for response strategies. RAMACHANDRAN, UMAMAHESWARI serves as the busiest examiner with 1 pending action under review. Practitioners can focus their immediate efforts on this specific examiner's requirements to resolve the company's outstanding prosecution matters.
This focus simplifies the administration of the current prosecution cycle. The company can dedicate its resources to overcoming the specific technical objections raised by the assigned examiner. Such a concentrated workload allows for a precise and targeted approach to securing intellectual property rights.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMACHANDRAN, UMAMAHESWARI | 1 | 54.9% | +53.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18794419 | AMINO-ARYL-BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOF | RAMACHANDRAN, UMAMAHESWARI | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18794419 | AMINO-ARYL-BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOF | RAMACHANDRAN, UMAMAHESWARI | 1627 | §112DP | Final Rejection | — | Pending | Aug 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHepanova Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Umamaheswari Ramachandran has the most, with 1 of Hepanova Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.